Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8996230 | 1.00 | KMT2A (0.39) | KMT2AMEN1DGKAVCAM1PTGS2 | |
| SCHEMBL8996129 | 1.00 | KMT2A (0.39) | KMT2AMEN1DGKAVCAM1PTGS2 | |
| SCHEMBL3537007 | 0.98 | KMT2A (0.40) | KMT2AMEN1DGKAVCAM1PTGS2 | |
| SCHEMBL3536100 | 0.92 | KMT2A (0.41) | KMT2AMEN1VCAM1LMNATSHR | |
| SCHEMBL25495837 | 0.92 | KMT2A (0.43) | KMT2AMEN1DGKAVCAM1LMNA | |
| SCHEMBL522462 | 0.92 | KMT2A (0.43) | KMT2AMEN1DGKAVCAM1LMNA | |
| SCHEMBL21049231 | 0.92 | KMT2A (0.43) | KMT2AMEN1DGKAVCAM1LMNA | |
| SCHEMBL4953772 | 0.90 | KMT2A (0.44) | KMT2AMEN1DGKAVCAM1LMNA | |
| SCHEMBL17337909 | 0.86 | KMT2A (0.48) | KMT2AMEN1DGKAVCAM1LMNA | |
| SCHEMBL7880107 | 0.85 | VCAM1 (0.43) | KMT2AMEN1DGKAVCAM1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4596563-A2 | ELECTROCHEMICAL BIOSENSOR COMPRISING TRANSITION METAL COMPLEX OR OXIDATION-REDUCTION POLYMER | i-Sens, Inc. (KR) | 2025-08-06 | — | — | EP | disclosed |
| US-20250244282-A1 | ELECTROCHEMICAL BIOSENSOR COMPRISING TRANSITION METAL COMPLEX OR OXIDATION-REDUCTION POLYMER | I SENS INC (KR) | 2025-07-31 | — | — | US | disclosed |
| US-20090325947-A1 | NITRATE ESTERS OF PIPERIDINES | NOVARTIS AG (CH) | 2009-12-31 | — | — | US | disclosed |
| US-20090318432-A1 | Nitrate esters of aminoalcohols | SPEEDEL EXPERIMENTA AG (CH) | 2009-12-24 | — | — | US | disclosed |
| CN-101522610-A | Nitrate esters of amino alcohols | SPEEDEL EXPERIMENTA AG (CH) | 2009-09-02 | — | — | CN | disclosed |
| EP-2061751-A1 | NITRATE ESTERS OF AMINOALCOHOLS | Novartis Ag (CH) | 2009-05-27 | — | — | EP | disclosed |
| EP-2049514-A1 | NITRATE ESTERS OF PIPERIDINES | Speedel Experimenta AG (CH) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008031811-A1 | NITRATE ESTERS OF AMINOALCOHOLS | SPEEDEL EXPERIMENTA AG (CH) | 2008-03-20 | — | — | WO | disclosed |
| WO-2008017685-A1 | NITRATE ESTERS OF PIPERIDINES | SPEEDEL EXPERIMENTA AG (CH) | 2008-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250244282-A1 | ELECTROCHEMICAL BIOSENSOR COMPRISING TRANSITION METAL COMPLEX OR OXIDATION-REDUCTION POLYMER | APEX1, SPR, MT-ND6 | KMT2A 1927/4885MEN1 3722/4885DGKA 4800/4885 |
| US-20090318432-A1 | Nitrate esters of aminoalcohols | NOS2, NOS1, NOS3 | KMT2A 3095/4885MEN1 3890/4885DGKA 2491/4885 |
| US-20090325947-A1 | NITRATE ESTERS OF PIPERIDINES | NOS2, NOS1, NOS3 | KMT2A 3329/4885MEN1 3438/4885DGKA 4020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.